Ticker
PHATCompany Name
PHATHOM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
---|---|---|---|
6/30/2025 | $ 733K | $ -257.49M | $ -256.75M |
3/31/2025 | $ 758K | $ -272.88M | $ -272.12M |
12/31/2024 | $ 795K | $ -262.32M | $ -261.52M |
9/30/2024 | $ 787K | $ -273M | $ -272.21M |
6/30/2024 | $ 717K | $ -239.04M | $ -238.33M |
3/31/2024 | $ 643K | $ -196.71M | $ -196.07M |
12/31/2023 | $ 575K | $ -159.62M | $ -159.05M |
9/30/2023 | $ 558K | $ -138.53M | $ -137.97M |
6/30/2023 | $ 612K | $ -147.21M | $ -146.59M |
3/31/2023 | $ 638K | $ -161.11M | $ -160.47M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT + DepAmor
(=) EBITDA
EBITDA for PHATHOM PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -169.03M ] + DepAmor [ $ 223K ]
(=) EBITDA [ $ -168.81M ]
Minimum
Sep 30, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.25K |
---|---|
min | $ -493.3M |
max | $ 590.6M |
average | $ 58.79M |
median | $ 8.83M |
std | $ 166.94M |